All-trans retinoic acid and protein kinase C α/β1 inhibitor combined treatment targets cancer stem cells and impairs breast tumor progression
Abstract Breast cancer is the leading cause of cancer death among women worldwide. Blocking a single signaling pathway is often an ineffective therapy, especially in the case of aggressive or drug-resistant tumors. Since we have previously described the mechanism involved in the crosstalk between Re...
Guardado en:
Autores principales: | Damian Emilio Berardi, Lizeth Ariza Bareño, Natalia Amigo, Luciana Cañonero, Maria de las Nieves Pelagatti, Andrea Nora Motter, María Agustina Taruselli, María Inés Díaz Bessone, Stefano Martin Cirigliano, Alexis Edelstein, María Giselle Peters, Miriam Diament, Alejandro Jorge Urtreger, Laura Beatriz Todaro |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/01e93465ea7b4915836df1684987bcd4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ACTION OF ALL-TRANS-RETINOIC ACID ON THE FLOOR OF THE MOUTH STRUCTURES OF RAT FETUSES
por: Gomes Totti,Valéria Maria, et al.
Publicado: (2001) -
Nanoparticle delivery and combination therapy of gambogic acid and all-trans retinoic acid
por: Yao J, et al.
Publicado: (2014) -
Development of a novel microemulsion for oral absorption enhancement of all-trans retinoic acid
por: Subongkot T, et al.
Publicado: (2017) -
Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer
por: Hemant M. Kocher, et al.
Publicado: (2020) -
Distinct Characteristics of Sweet’s Syndrome of the Scrotum Caused by All-trans Retinoic Acid in a Patient with Acute Promyelocytic Leukemia
por: Osamu Imataki, et al.
Publicado: (2021)